Brief Communication: Maternal Plasma Autoantibodies Screening in Fetal Down Syndrome.

about

Maternal plasma angiogenic and inflammatory factor profiling in foetal Down syndrome.

P2860

Q47103321-B216F0E0-A59E-420A-950A-C345FD5592F7

P2860

Brief Communication: Maternal Plasma Autoantibodies Screening in Fetal Down Syndrome.

Item

http://www.wikidata.org/entity/Q36706466

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Brief Communication: Maternal Plasma Autoantibodies Screening in Fetal Down Syndrome.

@ast

Brief Communication: Maternal Plasma Autoantibodies Screening in Fetal Down Syndrome.

@en

type

Item

label

Brief Communication: Maternal Plasma Autoantibodies Screening in Fetal Down Syndrome.

@ast

Brief Communication: Maternal Plasma Autoantibodies Screening in Fetal Down Syndrome.

@en

prefLabel

Brief Communication: Maternal Plasma Autoantibodies Screening in Fetal Down Syndrome.

@ast

Brief Communication: Maternal Plasma Autoantibodies Screening in Fetal Down Syndrome.

@en

P1476

Brief Communication: Maternal Plasma Autoantibodies Screening in Fetal Down Syndrome.

@en

P2093

Adam Lemancewicz

http://www.w3.org/2001/XMLSchema#string

Karol Charkiewicz

http://www.w3.org/2001/XMLSchema#string

Monika Zbucka-Kretowska

http://www.w3.org/2001/XMLSchema#string

P2860

Linear models and empirical bayes methods for assessing differential expression in microarray experiments

Normalization of cDNA microarray data

A human homologue of Drosophila minibrain (MNB) is expressed in the neuronal regions affected in Down syndrome and maps to the critical region

Maternal plasma and amniotic fluid sphingolipids profiling in fetal Down syndrome

Estimates for the sensitivity and false-positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustment for cross-identification and double-positive results.

Application of proteomics for the identification of differentially expressed protein markers for Down syndrome in maternal plasma.

DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study.

Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study.

Maternal plasma and amniotic fluid chemokines screening in fetal Down syndrome

Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy.

P304

9362169

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2016/9362169

http://www.w3.org/2001/XMLSchema#string

P478

2016

http://www.w3.org/2001/XMLSchema#string

P50

Joanna Goscik

Slawomir Wolczynski

Piotr Laudanski

P577

2016-03-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

297169741

http://www.w3.org/2001/XMLSchema#string

P698

27042674

http://www.w3.org/2001/XMLSchema#string

P921

autoantibody

P932

4799815

http://www.w3.org/2001/XMLSchema#string

Brief Communication: Maternal Plasma Autoantibodies Screening in Fetal Down Syndrome.

about

P2860

P2860

Brief Communication: Maternal Plasma Autoantibodies Screening in Fetal Down Syndrome.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P921

P932